{
    "ticker": "ATRC",
    "name": "AtriCure, Inc.",
    "description": "AtriCure, Inc. is a medical device company specializing in the development and commercialization of innovative technologies for the treatment of atrial fibrillation (AF) and other cardiac arrhythmias. Founded in 2000 and headquartered in Mason, Ohio, AtriCure is driven by its commitment to improving patient outcomes through its advanced surgical solutions. The company offers a range of products that include energy-based technologies for cardiac tissue ablation, which are designed to restore normal heart rhythm while minimizing damage to surrounding tissue. AtriCure's flagship products, such as the Isolator\u2122 Synergy Ablation System, have gained recognition for their effectiveness in treating AF during surgical procedures. With a focus on both the surgical and minimally invasive markets, AtriCure is at the forefront of innovation in the cardiac space, continuously conducting research to expand its product portfolio and enhance its existing technologies. The company is also dedicated to education and training, providing resources for surgeons and healthcare professionals to improve their skills in treating AF. AtriCure's mission is to transform the treatment landscape for arrhythmias, ultimately leading to better health outcomes for patients worldwide.",
    "industry": [
        "Medical Devices",
        "Healthcare"
    ],
    "headquarters": "Mason, Ohio, USA",
    "founded": "2000",
    "website": "https://www.atricure.com",
    "ceo": "John L. McCutcheon",
    "social_media": {
        "twitter": "https://twitter.com/AtriCure",
        "linkedin": "https://www.linkedin.com/company/atricure"
    },
    "investor_relations": "https://investor.atricure.com",
    "key_executives": [
        {
            "name": "John L. McCutcheon",
            "position": "CEO"
        },
        {
            "name": "J. Michael McCormick",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Ablation Technologies",
            "products": [
                "Isolator\u2122 Synergy Ablation System",
                "AtriClip\u2122"
            ]
        },
        {
            "category": "Minimally Invasive Solutions",
            "products": [
                "AtriCure\u00ae Fibrillation Solutions"
            ]
        }
    ],
    "seo": {
        "meta_title": "AtriCure, Inc. | Innovative Solutions for Atrial Fibrillation",
        "meta_description": "Explore AtriCure, Inc., a leader in medical devices dedicated to treating atrial fibrillation and improving patient outcomes through innovative surgical technologies.",
        "keywords": [
            "AtriCure",
            "Medical Devices",
            "Atrial Fibrillation",
            "Cardiac Arrhythmias",
            "Surgical Solutions"
        ]
    },
    "faq": [
        {
            "question": "What does AtriCure specialize in?",
            "answer": "AtriCure specializes in developing medical devices for the treatment of atrial fibrillation and cardiac arrhythmias."
        },
        {
            "question": "Who is the CEO of AtriCure?",
            "answer": "John L. McCutcheon is the CEO of AtriCure, Inc."
        },
        {
            "question": "Where is AtriCure headquartered?",
            "answer": "AtriCure is headquartered in Mason, Ohio, USA."
        },
        {
            "question": "What are AtriCure's main products?",
            "answer": "AtriCure's main products include the Isolator\u2122 Synergy Ablation System and AtriClip\u2122."
        },
        {
            "question": "When was AtriCure founded?",
            "answer": "AtriCure was founded in 2000."
        }
    ],
    "competitors": [
        "ISRG",
        "ZBH",
        "SYK",
        "MDT"
    ],
    "related_stocks": [
        "JNJ",
        "ABBV",
        "BMY",
        "PFE"
    ]
}